Clinical trial
A Study Of GW406381 In Volunteers With Moderate Hepatic Impairment
NCT00373243 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00373243 |
|---|---|
| Title | A Study Of GW406381 In Volunteers With Moderate Hepatic Impairment |
| Official title | An Open-label, Non-randomised Study of 20 mg GW406381 Single Dose Pharmacokinetics in Healthy Subjects and in Volunteers With Moderate Hepatic Impairment |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | GW406381 |
| Enrollment | 24 |
| Start date | Oct 19, 2005 |
| Primary completion | Sep 26, 2006 |
| Completion | Sep 26, 2006 |
| First posted | Sep 7, 2006 |
| Last update posted | Sep 11, 2017 |
| Countries | Hungary |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: